Invention Grant
- Patent Title: Pharmaceutical compositions for the treatment of Helicobacter pylori
-
Application No.: US15135309Application Date: 2016-04-21
-
Publication No.: US09603806B2Publication Date: 2017-03-28
- Inventor: Reza Fathi , Gilead Raday , Guy Goldberg , Patrick Gosselin
- Applicant: RedHill Biopharma Ltd.
- Applicant Address: IL Tel-Aviv
- Assignee: RedHill Biopharma Ltd.
- Current Assignee: RedHill Biopharma Ltd.
- Current Assignee Address: IL Tel-Aviv
- Agency: Greenberg Traurig, LLP
- Main IPC: A61K9/48
- IPC: A61K9/48 ; A61K31/43 ; A61K31/435 ; A61K31/438 ; A61K31/4439 ; A61K9/50

Abstract:
Single oral solid dosage form comprising an immediate release first dosage composition having at least two antibiotic agents and a delayed release second dosage composition having a proton pump inhibitor are provided herein. The single oral solid dosage form according to some aspects of the invention can be used for the treatment of disorders associated with infection by H. pylori or the prevention of recurrence of disorders associated with infection by H. pylori.
Public/Granted literature
- US20160235681A1 PHARMACEUTICAL COMPOSITIONS FOR THE TREATMENT OF HELICOBACTER PYLORI Public/Granted day:2016-08-18
Information query